Updated Jul 16, 2026
Emany Sravan Kumar has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $215K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | ASRT | Assertio Holdings, Inc. | J — Other acquisition / disposition | 23.9K | $0.00 | |
| 2026-05-06 | ASRT | Assertio Holdings, Inc. | A — Grant or award | 4.9K | $0.00 | |
| 2026-04-02 | BEAM | Beam Therapeutics Inc. | A — Grant or award | 31.8K | $0.00 | |
| 2026-02-26 | KYTX | Kyverna Therapeutics, Inc. | A — Grant or award | 11.0K | $0.00 | |
| 2026-01-05 | BEAM | Beam Therapeutics Inc. | S — Open-market sale [10b5-1] | 6.3K | $27.10 | $171K |
| 2024-11-20 | IRWD | IRONWOOD PHARMACEUTICALS INC | S — Open-market sale | 11.0K | $4.08 | $45K |
Emany Sravan Kumar is a corporate insider — currently tracked as Director of Assertio Holdings, Inc. (ASRT). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($215K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Emany Sravan Kumar profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.